Valuation: DRI Healthcare Trust

Market Cap 708M 629M 588M 536M 1.01B 68.16B 1.02B 7.11B 2.75B 34.71B 2.66B 2.6B 111B P/E 2026 *
21.5x
P/E 2027 * 20.6x
Enterprise Value 1.25B 1.11B 1.04B 945M 1.78B 120B 1.8B 12.55B 4.86B 61.24B 4.69B 4.59B 197B EV / Sales 2026 *
6.43x
EV / Sales 2027 * 5.15x
Free-Float
99.76%
Yield 2026 *
3.33%
Yield 2027 * 3.51%

Last Transcript: DRI Healthcare Trust

1 day+0.25%
1 week-0.08%
Current month+0.25%
1 month+3.06%
3 months-0.78%
6 months+10.17%
Current year+14.22%
1 week 17.83
Extreme 17.83
18.9
1 month 16.3
Extreme 16.3
18.97
Current year 15
Extreme 15
19.75
1 year 14.1
Extreme 14.1
19.75
3 years 10.21
Extreme 10.21
19.75
5 years 5.83
Extreme 5.83
19.75
10 years 5.83
Extreme 5.83
19.75
Manager TitleAgeSince
Chief Executive Officer 51 2020-05-31
Director of Finance/CFO - 2025-09-30
Chief Tech/Sci/R&D Officer - 2014-08-31
Director TitleAgeSince
Chairman 63 2021-01-21
Director/Board Member 51 2020-05-31
Director/Board Member 66 2021-01-21
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Option

Chairman

-3,008 0.0055%
9/1/26 Option

Chairman

1,397 0.0025%
9/1/26 Option

Chairman

1,397 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%-0.08%+24.44%+71.70% 708M
-0.62%-2.71%+39.30%+114.07% 1,025B
-2.30%-4.44%+39.03%+66.07% 623B
-0.63%-1.96%+6.36%+74.38% 459B
-1.03%-2.82%+59.56%+39.69% 355B
-0.29%-3.47%+22.34%+40.21% 336B
-0.49%-1.92%+12.96%+25.84% 270B
+0.02%-4.08%-3.32%+9.95% 247B
-3.38%+0.30%+36.44%+51.54% 220B
-1.04%-1.46%+32.70%+96.82% 183B
Average -0.17%-1.71%+26.98%+59.03% 371.89B
Weighted average by Cap. +0.12%-2.11%+30.35%+69.48%

Financials

2026 *2027 *
Net sales 194M 172M 161M 147M 277M 18.69B 280M 1.95B 755M 9.52B 729M 713M 30.57B 225M 200M 187M 170M 321M 21.69B 325M 2.26B 876M 11.04B 846M 827M 35.48B
Net income 30.3M 26.91M 25.16M 22.93M 43.17M 2.92B 43.76M 304M 118M 1.49B 114M 111M 4.77B 27.05M 24.03M 22.47M 20.47M 38.55M 2.6B 39.08M 272M 105M 1.33B 102M 99.36M 4.26B
Net Debt 541M 481M 449M 409M 771M 52.09B 782M 5.44B 2.1B 26.53B 2.03B 1.99B 85.2B 452M 401M 375M 342M 643M 43.47B 652M 4.54B 1.76B 22.14B 1.7B 1.66B 71.11B
Logo DRI Healthcare Trust
DRI Healthcare Trust is a global pharmaceutical royalty monetization company. The Company's portfolio consists of 29 royalty streams on 23 products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. Its Royalty Assets include Ekterly, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Spinraza, Vonjo I, Vonjo II, Xolair, Zejula, Zytiga, and others. The Ekterly is an oral on-demand therapy for treating attacks associated with Hereditary Angioedema (HAE). The Eylea I is a vascular endothelial growth factor inhibitor initially indicated for the treatment of neovascular wet age-related macular degeneration. Natpara is indicated as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism.
Employees
32
Date Price Change Volume
26-10-01 $18.36 +0.25% 21,096
26-09-30 $18.31 -0.38% 15,550
26-09-29 $18.38 -1.39% 35,800
26-09-28 $18.64 +1.03% 39,719
26-09-25 $18.45 +0.44% 39,681
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
12.88USD
Average target price
17.17USD
Spread / Average Target
+33.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DHT.U Stock